scPharmaceuticals (SCPH) News Today $3.29 -0.23 (-6.53%) As of 05/20/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock SCPH Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Stonepine Capital Management LLC Has $2.42 Million Stock Holdings in scPharmaceuticals Inc. (NASDAQ:SCPH)Stonepine Capital Management LLC lowered its holdings in shares of scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) by 12.2% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 683,530 shares of the company's stock after selling 95,344 shMay 20 at 6:47 AM | marketbeat.comLeerink Partnrs Has Bearish Forecast for SCPH Q2 EarningsMay 20 at 1:34 AM | americanbankingnews.comLeerink Partnrs Analysts Lower Earnings Estimates for SCPHscPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) - Stock analysts at Leerink Partnrs dropped their Q2 2025 earnings estimates for shares of scPharmaceuticals in a research report issued on Wednesday, May 14th. Leerink Partnrs analyst R. Ruiz now anticipates that the company will earn ($0.37) peMay 20 at 1:31 AM | marketbeat.comSuvretta Capital Management LLC Reduces Stake in scPharmaceuticals Inc. (NASDAQ:SCPH)Suvretta Capital Management LLC decreased its stake in shares of scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) by 10.2% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 1,840,891 shares of the company's stock after selling 208,118 sMay 19 at 7:41 AM | marketbeat.comWhat is Leerink Partnrs' Forecast for SCPH FY2027 Earnings?May 18 at 3:51 AM | americanbankingnews.comWhat is HC Wainwright's Forecast for SCPH Q1 Earnings?May 18 at 2:57 AM | americanbankingnews.comscPharmaceuticals First Quarter 2025 Earnings: Revenues Beat Expectations, EPS LagsMay 16, 2025 | finance.yahoo.comscPharmaceuticals Inc. (NASDAQ:SCPH) Q1 2025 Earnings Call TranscriptMay 16, 2025 | insidermonkey.comScPharmaceuticals targets CKD launch and rising Medicare fill rates to accelerate FUROSCIX growth trajectoryMay 16, 2025 | msn.comScPharmaceuticals targets CKD launch and rising Medicare fill rates to accelerate FUROSCIX growth trajectoryMay 16, 2025 | msn.comQ1 2025 scPharmaceuticals Inc Earnings CallMay 16, 2025 | finance.yahoo.comQ1 2025 scPharmaceuticals Inc Earnings CallMay 16, 2025 | finance.yahoo.comscPharmaceuticals Inc. (SCPH) Q1 2025 Earnings Call TranscriptMay 15, 2025 | seekingalpha.comscPharmaceuticals Inc. Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 14, 2025 | globenewswire.comscPharmaceuticals Inc. (NASDAQ:SCPH) Stake Reduced by J. Goldman & Co LPJ. Goldman & Co LP cut its holdings in scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) by 11.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,219,127 shares of the company's stock afMay 14, 2025 | marketbeat.comInsights Ahead: scPharmaceuticals's Quarterly EarningsMay 13, 2025 | benzinga.comscPharmaceuticals (SCPH) Projected to Post Quarterly Earnings on TuesdayMay 12, 2025 | americanbankingnews.comscPharmaceuticals (SCPH) Expected to Announce Quarterly Earnings on TuesdayscPharmaceuticals (NASDAQ:SCPH) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 13. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-13-scpharmaceuticals-inc-stock/)May 8, 2025 | marketbeat.comscPharmaceuticals to Announce First Quarter 2025 Financial Results After the Market Close on May 14, 2025May 7, 2025 | globenewswire.comscPharmaceuticals Inc. (NASDAQ:SCPH) Shares Acquired by Apis Capital Advisors LLCApis Capital Advisors LLC raised its stake in shares of scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) by 146.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 394,000 shares of the company's stock afterMay 5, 2025 | marketbeat.comscPharmaceuticals Announces Participation in Three Upcoming Investor ConferencesMay 1, 2025 | globenewswire.comNantahala Capital Management LLC Boosts Holdings in scPharmaceuticals Inc. (NASDAQ:SCPH)Nantahala Capital Management LLC raised its stake in shares of scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) by 33.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,000,000 shaApril 30, 2025 | marketbeat.comGeode Capital Management LLC Boosts Holdings in scPharmaceuticals Inc. (NASDAQ:SCPH)Geode Capital Management LLC increased its holdings in scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) by 16.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 750,493 shares of the cApril 30, 2025 | marketbeat.comscPharmaceuticals Stock Price, Quotes and ForecastsApril 25, 2025 | benzinga.comAnalysts Are Bullish on These Healthcare Stocks: scPharmaceuticals (SCPH), Sarepta Therapeutics (SRPT)April 23, 2025 | markets.businessinsider.comscPharmaceuticals Inc. (NASDAQ:SCPH) Short Interest UpdatescPharmaceuticals Inc. (NASDAQ:SCPH - Get Free Report) was the recipient of a significant decline in short interest in the month of March. As of March 31st, there was short interest totalling 4,820,000 shares, a decline of 15.0% from the March 15th total of 5,670,000 shares. Currently, 10.2% of the company's shares are sold short. Based on an average daily volume of 441,300 shares, the days-to-cover ratio is currently 10.9 days.April 23, 2025 | marketbeat.comCraig-Hallum Sticks to Its Buy Rating for scPharmaceuticals (SCPH)March 22, 2025 | markets.businessinsider.comscPharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results with Major FDA Approval for FUROSCIXMarch 22, 2025 | nasdaq.comscPharmaceuticals (NASDAQ:SCPH) Given New $12.00 Price Target at Maxim GroupMaxim Group reduced their price target on scPharmaceuticals from $20.00 to $12.00 and set a "buy" rating for the company in a research report on Thursday.March 21, 2025 | marketbeat.comscPharmaceuticals Full Year 2024 Earnings: In Line With ExpectationsMarch 21, 2025 | finance.yahoo.comHC Wainwright Reiterates "Buy" Rating for scPharmaceuticals (NASDAQ:SCPH)HC Wainwright reiterated a "buy" rating and set a $18.00 target price on shares of scPharmaceuticals in a research note on Thursday.March 21, 2025 | marketbeat.comscPharmaceuticals price target lowered to $12 from $20 at MaximMarch 21, 2025 | markets.businessinsider.comscPharmaceuticals (NASDAQ:SCPH) Issues Earnings ResultsscPharmaceuticals (NASDAQ:SCPH - Get Free Report) posted its quarterly earnings data on Wednesday. The company reported ($0.35) EPS for the quarter, beating the consensus estimate of ($0.39) by $0.04. scPharmaceuticals had a negative return on equity of 244.93% and a negative net margin of 264.60%.March 20, 2025 | marketbeat.comscPharmaceuticals (NASDAQ:SCPH) Announces Quarterly Earnings ResultsscPharmaceuticals (NASDAQ:SCPH - Get Free Report) announced its earnings results on Wednesday. The company reported ($0.35) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.39) by $0.04. scPharmaceuticals had a negative return on equity of 244.93% and a negative net margin of 264.60%.March 20, 2025 | marketbeat.comQ4 2024 scPharmaceuticals Inc Earnings CallMarch 20, 2025 | finance.yahoo.comscPharmaceuticals reports Q 4EPS (35c), consensus (39c)March 20, 2025 | markets.businessinsider.comscPharmaceuticals Inc. (SCPH) Q4 2024 Earnings Call TranscriptMarch 19, 2025 | seekingalpha.comScPharmaceuticals outlines FUROSCIX expansion strategy with CKD launch in April 2025March 19, 2025 | msn.comscPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides ...March 19, 2025 | gurufocus.comscPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateMarch 19, 2025 | globenewswire.comscPharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on Wednesday, March 19, 2025March 12, 2025 | globenewswire.comKing Luther Capital Management Corp Buys 632,120 Shares of scPharmaceuticals Inc. (NASDAQ:SCPH)King Luther Capital Management Corp raised its stake in shares of scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) by 28.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,857,910 shareMarch 12, 2025 | marketbeat.comscPharmaceuticals announces FDA approval of Furoscix indication expansionMarch 7, 2025 | markets.businessinsider.comTD Cowen Keeps Their Buy Rating on scPharmaceuticals (SCPH)March 7, 2025 | markets.businessinsider.comFDA approves scPharmaceuticals’ Furoscix sNDA for oedema in CKDMarch 7, 2025 | finance.yahoo.comHC Wainwright Forecasts Lower Earnings for scPharmaceuticalsscPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) - Investment analysts at HC Wainwright dropped their FY2024 earnings per share estimates for shares of scPharmaceuticals in a report issued on Monday, March 3rd. HC Wainwright analyst D. Tsao now forecasts that the company will post earnings perMarch 7, 2025 | marketbeat.comscPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX® Indication to Include the Treatment of Edema in Patients with Chronic Kidney DiseaseMarch 6, 2025 | globenewswire.comBrokers Set Expectations for SCPH FY2029 EarningsscPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) - Stock analysts at HC Wainwright issued their FY2029 earnings per share estimates for scPharmaceuticals in a note issued to investors on Monday, March 3rd. HC Wainwright analyst D. Tsao expects that the company will earn $0.70 per share for theMarch 6, 2025 | marketbeat.comscPharmaceuticals (SCPH) Projected to Post Quarterly Earnings on WednesdayscPharmaceuticals (NASDAQ:SCPH) will be releasing earnings before the market opens on Wednesday, March 12, Financial Modeling Prep reports.March 5, 2025 | marketbeat.comscPharmaceuticals (NASDAQ:SCPH) Earns "Buy" Rating from HC WainwrightHC Wainwright reissued a "buy" rating and issued a $18.00 target price on shares of scPharmaceuticals in a report on Monday.March 3, 2025 | marketbeat.com Get scPharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SCPH and its competitors with MarketBeat's FREE daily newsletter. Email Address SCPH Media Mentions By Week SCPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SCPH News Sentiment▼0.160.65▲Average Medical News Sentiment SCPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SCPH Articles This Week▼242▲SCPH Articles Average Week Get scPharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SCPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Akebia Therapeutics News Nurix Therapeutics News Anavex Life Sciences News Immunome News Rocket Pharmaceuticals News ArriVent BioPharma News Day One Biopharmaceuticals News Trevi Therapeutics News Immatics News Vir Biotechnology News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SCPH) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding scPharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share scPharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SCPH Stock Free SCPH Stock Alerts